Huang Jiwei, Tang Wei, Hernandez-Alejandro Roberto, Bertens Kimberly A, Wu Hong, Liao Mingheng, Li Jiaxin, Zeng Yong
From the Department of Liver Surgery, Division of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, China (JH, HW, ML, JL, YZ); Department of Hepato-Biliary-Pancreatic Surgery, University of Tokyo Hospital, University of Tokyo, Tokyo, Japan (WT); Department of Hepato-Biliary-Pancreatic Surgery, London Health Sciences Centre, Western University, London, Canada (RHA, KAB).
Medicine (Baltimore). 2014 Dec;93(28):e288. doi: 10.1097/MD.0000000000000288.
To investigate whether the long-term outcomes of hepatocellular carcinoma (HCC) was adversely impacted by intermittent hepatic inflow occlusion (HIO) during hepatic resection.
1549 HCC patients who underwent hepatic resection between 1998 and 2008 were identified from a prospectively maintained database. Intermittent HIO was performed in 931 patients (HIO group); of which 712 patients had a Pringle maneuver as the mechanism for occlusion (PM group), and 219 patients had selective hemi-hepatic occlusion (SO group). There were 618 patients that underwent partial hepatectomy without occlusion (occlusion-free, OF group).
The 1-, 3-, and 5- year overall survival (OS) rates were 79%, 59%, and 42% in the HIO group, and 83%, 53%, and 35% in the OF group, respectively. The corresponding recurrence free survival (RFS) rates were 68%, 39%, and 22% in the HIO group, and 74%, 41%, and 18% in the OF group, respectively. There was no significant difference between the 2 groups in OS or RFS (P=0.325 and P=0.416). Subgroup analysis showed patients with blood loss over 3000 mL and those requiring transfusion suffered significantly shorter OS and RFS. Blood loss over 3000 mL and blood transfusion were independent risk factors to OS and RFS.
The application of intermittent HIO (PM and SO) during hepatic resection did not adversely impact either OS or RFS in patients with HCC. Intermittent HIO is still a valuable tool in hepatic resection, because high intraoperative blood loss resulting in transfusion is associated with a reduction in both OS and RFS.
探讨肝切除术中间歇性肝血流阻断(HIO)是否会对肝细胞癌(HCC)的长期预后产生不利影响。
从一个前瞻性维护的数据库中识别出1998年至2008年间接受肝切除术的1549例HCC患者。931例患者进行了间歇性HIO(HIO组);其中712例患者采用Pringle手法作为阻断机制(PM组),219例患者采用选择性半肝阻断(SO组)。有618例患者接受了无阻断的肝部分切除术(无阻断组,OF组)。
HIO组的1年、3年和5年总生存率(OS)分别为79%、59%和42%,OF组分别为83%、53%和35%。相应的无复发生存率(RFS)在HIO组分别为68%、39%和22%,在OF组分别为74%、41%和18%。两组在OS或RFS方面无显著差异(P=0.325和P=0.416)。亚组分析显示,失血超过3000毫升的患者和需要输血的患者的OS和RFS明显缩短。失血超过3000毫升和输血是OS和RFS的独立危险因素。
肝切除术中应用间歇性HIO(PM和SO)对HCC患者的OS或RFS均无不利影响。间歇性HIO仍是肝切除术中一种有价值的工具,因为术中大量失血导致输血与OS和RFS的降低有关。